Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Items 101–200 of 1,000
Smoking Bans in Psychiatric Inpatient Settings? A Review of the Research
Lawn, S., & Pols, R. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01697.x · Cited by 228
“More generally, central nervous system mesolimbic dopaminergic pathway activity has been found to be especially important in mediating reward in nicotine dependence [39,40].”
BackgroundFehr, C., Yakushev, I., Hohmann, N., Buchholz, H.-G., Landvogt, C., Deckers, H., Eberhardt, A., Kläger, M., Smolka, M. N., Scheurich, A., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07020352 · Cited by 226
“Like other drugs of abuse, nicotine provokes a sustained dopamine release in the nucleus accumbens, as shown by rat microdialysis experiments, that is important for the development of substance dependence (4).”
BackgroundBerrendero, F., Kieffer, B. L., & Maldonado, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10935.2002 · Cited by 222
“In addition, the activation of both -opioid receptors and nAChRs induces release of dopamine in the shell of the nucleus accumbens (Pontieri et al., 1996).”
BackgroundInfluentialHuman α6 AChR subtypes: subunit composition, assembly, and pharmacological responses
Kuryatov, A., Olale, F., Cooper, J., Choi, C., & Lindstrom, J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00144-1 · Cited by 226
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Invertebrate models of drug abuse
Wolf, F. W., & Heberlein, U. (2003) · Journal of Neurobiology · doi:10.1002/neu.10166 · Cited by 214
“As is the case for most drugs of abuse, nicotine acts on brain reward centers, including the mesolimbic dopamine system in rodents (Pontieri et al., 1996; Di Chiara, 2000).”
BackgroundPeculiar vulnerability to nicotine oral self-administration in mice during early adolescence
Adriani, W. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00295-6 · Cited by 214
“In the present study, we were interested in nicotine, which beside being the main psychoactive compound implied in tobacco smoking, also shares most of the characteristics of other addictive drugs (Corrigall et al. 1992,1994; Pontieri et al. 1996; Merlo-Pich et al. 1997; Stolerman 1999).”
Benowitz, N. L. (1999) · Primary Care: Clinics in Office Practice · doi:10.1016/s0095-4543(05)70120-2 · Cited by 203
The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent
Barrot, M., Marinelli, M., Abrous, D. N., Rougé‐Pont, F., Le Moal, M., & Piazza, P. V. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00996.x · Cited by 210
Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Scheibal, D., Hahn, E., Shiraga, S., Zamora-Paja, E., Farahi, J., Saxena, S., London, E. D., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.808 · Cited by 209
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
“Microdialysis (Damsma et al., 1989; Di Chiara and Imperato, 1988; Pontieri et al., 1996; Sziraki et al., 2001) and lesion (Corrigall et al., 1992) studies in rats indicate that nicotineinduced DA release is strongest in this region, and is more robust than the DA release found in associated…”
BackgroundResultInfluentialDaily smoking and the subsequent onset of psychiatric disorders
BRESLAU, N., NOVAK, S. P., & KESSLER, R. C. (2004) · Psychological Medicine · doi:10.1017/s0033291703008869 · Cited by 200
Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2003) · Synapse · doi:10.1002/syn.10238 · Cited by 197
“It has been demonstrated that drugs of abuse such as morphine, cocaine, and nicotine enhance DA release preferentially in the shell portion of the nucleus accumbens rather than in the core (Pontieri et al., 1995, 1996).”
BackgroundTanda, G., & Di Chiara, G. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00135.x · Cited by 197
Self-citationFunctional Specificity of Ventral Striatal Compartments in Appetitive Behaviors
KELLEY, A. E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09262.x · Cited by 198
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 200
“Specifically, nicotine activation of presynaptic nicotinic acetylcholine receptors (nAChRs) releases dopamine in critical brain reward circuits (Pontieri et al., 1996).”
BackgroundLerman, C., Jepson, C., Wileyto, E. P., Epstein, L. H., Rukstalis, M., Patterson, F., Kaufmann, V., Restine, S., Hawk, L., Niaura, R., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300861 · Cited by 197
“There is abundant empirical support for the role of dopamine in the rewarding effects of nicotine (Balfour, 2004; Di Chiara and Imperato, 1988; Pontieri et al, 1996).”
BackgroundNeural integrative activities of nucleus accumbens subregions in relation to learning and motivation
Kelley, A. E. (1999) · Psychobiology · doi:10.3758/bf03332114 · Cited by 195
Sudweeks, S. N., & Yakel, J. L. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00515.x · Cited by 197
“…as Alzheimer’s disease (Perry et al. 1995), epilepsy (Steinlein et al. 1995), schizophrenia (Freedman et al. 1997), cognition (Levin, 1992; Changeux et al. 1998), tobacco addiction (Pontieri et al. 1996) and even cell proliferation and differentiation in the developing CNS (McFarland et al. 1991).”
BackgroundPidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T., & Dani, J. A. (2004) · Learning & Memory · doi:10.1101/lm.70004 · Cited by 196
The Effects of Nicotine on Neural Pathways Implicated in Depression
Balfour, D. J. K., & Ridley, D. L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00205-7 · Cited by 195
Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse
Willuhn, I., Wanat, M. J., Clark, J. J., & Phillips, P. E. M. (2010) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_27 · Cited by 193
“…cannabinoids, nicotine, and ethanol increase dopamine levels in the NAcc (Di Chiara and Imperato 1986; Imperato and Di Chiara 1986; Imperato et al. 1986; Di Chiara and Imperato 1988; Kalivas and Duffy 1990; Kuczesnki et al. 1991; Yoshimoto et al. 1992; Pontieri et al. 1996; Tanda et al. 1997).”
Cardoso, R. A., Brozowski, S. J., Chavez-Noriega, L. E., Harpold, M., Valenzuela, C. F., & Harris, R. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38200-x · Cited by 192
Acquas, E. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00290-7 · Cited by 186
“…have shown that a neurochemical property common to psychostimulant and reinforcing drugs is the ability of preferentially stimulating DA release in the shell subdivision of the nucleus accumbens (Cadoni and Di Chiara 1999, 2000; Di Chiara 1999; Pontieri et al. 1995, 1996; Tanda et al. 1997).”
BackgroundCadoni, C., & Di Chiara, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00466-7 · Cited by 184
Self-citationVentral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette
Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Allen-Martinez, Z., Scheibal, D., Abrams, A. L., Costello, M. R., Farahi, J., Saxena, S., Monterosso, J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.87 · Cited by 183
“In studies of rodents, nicotine-induced DA release in the VST/NAc was shown using microdialysis (Di Chiara and Imperato, 1988; Damsma et al, 1989; Pontieri et al, 1996; Sziraki et al, 2001), whereas nicotine-induced DA release was disrupted by lesioning of dopaminergic neurons prior to nicotine…”
BackgroundOpen-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor
Buisson, B., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.555 · Cited by 179
“The addictive properties of nicotine are well documented in rodents, and it was shown that nicotine stimulates dopamine transmission in the nucleus accumbens (Pontieri et al., 1996) in a manner similar to that of cocaine (Merlo Pich et al.”
Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine
Cadoni, C., & Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00843-2 · Cited by 180
The Genetic Determinants of Smoking
Batra, V., Patkar, A. A., Berrettini, W. H., Weinstein, S. P., & Leone, F. T. (2003) · Chest · doi:10.1378/chest.123.5.1730 · Cited by 175
Barrett, S. P., Boileau, I., Okker, J., Pihl, R. O., & Dagher, A. (2004) · Synapse · doi:10.1002/syn.20066 · Cited by 173
“…leads to increased DA cell firing in the ventral tegmental area (Corrigall et al., 1994) and increased DA release in the nucleus accumbens (Pontieri et al., 1996), actions thought to be critical to the reinforcing properties of several addictive substances (Wise 1996; Di Chiara and…”
BackgroundA pharmacologic strategy for the treatment of nicotine addiction
Dewey, S. L., Brodie, J. D., Gerasimov, M., Horan, B., Gardner, E. L., & Ashby, C. R. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199901)31:1<76::aid-syn10>3.0.co;2-y · Cited by 178
“…with other drugs of abuse the property of producing an increase in extracellular DA levels in the nucleus accumbens (NAc), an important component of the reward system (Damsma et al., 1989; Di Chiara and Imperato, 1988; Imperato et al., 1986; Nisell et al., 1994a, 1995; Pontieri et al., 1997).”
BackgroundBiological Aspects of the Link between Smoking and Depression
Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176
In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice
Brunzell, D. H., Russell, D. S., & Picciotto, M. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01640.x · Cited by 176
Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability
Fowler, C. D., & Kenny, P. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.008 · Cited by 169
“Indeed, nicotine-induced activation of a4b2* nAChRs in the VTA increases forebrain dopamine transmission, most prominently in the shell region of the nucleus accumbens (NAc), and this has been shown to contribute to the reinforcing properties of the drug in laboratory animals (Iyaniwura et al., 2001; Nisell et al., 19…”
Bupropion: A Review of its Use in the Management of Smoking Cessation
Holm, K. J., & Spencer, C. M. (2000) · Drugs · doi:10.2165/00003495-200059040-00019 · Cited by 175
Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD)
Ohlmeier, M. D., Peters, K., Wildt, B. T. T., Zedler, M., Ziegenbein, M., Wiese, B., Emrich, H. M., & Schneider, U. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn014 · Cited by 174
“The unpaired t-test was used to compare means between two groups.”
BackgroundMethodCarboni, E., Silvagni, A., Rolando, M. T. P., & Di Chiara, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-j0002.2000 · Cited by 170
“This is further demonstrated by the fact that clear-cut differences in the effect of drugs of abuse can be obtained within the NAc itself between medial and lateral locations 1 mm apart (Pontieri et al., 1996; Tanda et al., 1997b).”
Self-citationWeiser, M., Reichenberg, A., Grotto, I., Yasvitzky, R., Rabinowitz, J., Lubin, G., Nahon, D., Knobler, H. Y., & Davidson, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1219 · Cited by 171
“Similarly, nicotine, like cocaine and amphetamine, activates mesolimbic dopamine neurotransmission (37), which is of critical importance in reinforcing and reward (38), and future schizophrenia patients often suffer from nonpsychotic psychiatric symptoms (23) and/or depression (39).”
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine
Cadoni, C., Solinas, M., & Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00824-9 · Cited by 172
Self-citationDopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine
Zhang, T., Zhang, L., Liang, Y., Siapas, A. G., Zhou, F.-M., & Dani, J. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0261-09.2009 · Cited by 164
“Another distinguishing property is that addictive drugs (including nicotine) initially increase the basal DA concentration in the NAc shell as measured by microdialysis, but that increase is smaller or not detected in the dorsolateral striatum (Pontieri et al., 1996; Di Chiara, 1999; Pidoplichko et al., 2004).”
BackgroundSvenningsson, P., Nomikos, G. G., Ongini, E., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00046-8 · Cited by 170
Tanda, G., Pontieri, F. E., Frau, R., & Di Chiara, G. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01375.x · Cited by 169
Self-citationBergen, A. W., & Caporaso, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.16.1365 · Cited by 158
Paperwalla, K. N., Levin, T. T., Weiner, J., & Saravay, S. M. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.06.007 · Cited by 164
“The biologic mechanism of nicotine addiction may be caused by the selective release of dopamine in the nucleus accumbens that results in c-fos gene expression, a pathway activated by other addictive drugs, such as cocaine, amphetamine, and morphine [54].”
BackgroundSchroeder, B. E., Binzak, J. M., & Kelley, A. E. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00221-4 · Cited by 162
High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers
Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164
“In animal studies, nicotine, the neuroactive compound of tobacco, releases dopamine and stimulates energy metabolism in the basal ganglia, and especially in the ventral tegmental area and nucleus accumbens (4), which have been suggested to be central in reinforcing the effect of addictive compounds (5).”
BackgroundQuarta, D., Ferré, S., Solinas, M., You, Z., Hockemeyer, J., Popoli, P., & Goldberg, S. R. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02245.x · Cited by 163
“…induced by caffeine in the present study and our previous study (Solinas et al. 2002) are in the same range as increases induced by the systemic administration of nicotine, delta-9-tetrahydrocannabinol, morphine or ethanol (Di Chiara and Imperato 1988; Chen et al. 1991; Pontieri et al. 1995, 1996).”
ResultGuillem, K., Vouillac, C., Azar, M. R., Parsons, L. H., Koob, G. F., Cador, M., & Stinus, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2139-05.2005 · Cited by 158
“Nicotine is the neuroactive compound that is considered to be most responsible for the psychoactive properties of tobacco and the development and maintenance of tobacco addiction (Jaffe and Kanzler, 1979; Stolerman and Jarvis, 1995; Pontieri et al., 1996).”
BackgroundNicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162
Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum
Zhang, L., Doyon, W. M., Clark, J. J., Phillips, P. E. M., & Dani, J. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056317 · Cited by 161
“Much research has shown that the striatum and the midbrain DA neurons that innervate the striatum are important sites of action for nicotine (Grenhoff et al., 1986; Pontieri et al., 1996; Zhou et al., 2001; Picciotto and Corrigall, 2002; Mansvelder et al., 2003; Rice and Cragg, 2004; Zhang and Sulzer, 2004; Dani and H…”
BackgroundDopamine and addiction: what have we learned from 40 years of research
Solinas, M., Belujon, P., Fernagut, P., Jaber, M., & Thiriet, N. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1957-2 · Cited by 181
Monoamine oxidase and tobacco dependence
Lewis, A., Miller, J. H., & Lea, R. A. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.019 · Cited by 177
Psychostimulant-Induced Behavioral Sensitization Depends on Nicotinic Receptor Activation
Schoffelmeer, A. N. M., De Vries, T. J., Wardeh, G., van de Ven, H. W. M., & Vanderschuren, L. J. M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03269.2002 · Cited by 157
“…studies indicated that activation of nicotinic receptors increases the activity of distinct neurons throughout the brain, including mesocorticolimbic dopamine and glutamate neurons (McGhee et al., 1995; Pontieri et al., 1996; Marshall et al., 1997; Wonnacott, 1997; Reid et al., 2000).”
BackgroundHypothalamic–Pituitary–Adrenocortical responses to psychological stress and risk for smoking relapse
al'Absi, M. (2006) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.10.010 · Cited by 158
Sensitization of the Mesoaccumbens Dopamine Response to Nicotine
Balfour, D. J. K., Benwell, M. E. M., Birrell, C. E., Kelly, J., & Al-Aloul, M. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00537-6 · Cited by 160
Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Hawk, L. H., Pinto, A., Kucharski, S., Krishnan, S., Niaura, R., & Epstein, L. H. (2003) · Health Psychology · doi:10.1037/0278-6133.22.5.541 · Cited by 155
Collins, S. L., & Izenwasser, S. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.024 · Cited by 163
Brown, R. W., & Kolb, B. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02201-6 · Cited by 156
Nicotine self-administration in animals as a dependence model
Corrigall, W. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011121 · Cited by 156
Straub, R. E., Sullivan, P. F., Ma, Y., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Kadambi, B., Sadek, H., Silverman, M. A., Webb, B. T., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000518 · Cited by 161
Exposure to nicotine and sensitization of nicotine-induced behaviors
Vezina, P., McGehee, D. S., & Green, W. N. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.038 · Cited by 167
Corrigall, W., Coen, K. M., Adamson, K. L., Chow, B. L., & Zhang, J. (2000) · Psychopharmacology · doi:10.1007/s002139900355 · Cited by 171
“These findings are in accord with a large body of other data on the response, and the adaptation, of the mesolimbic dopamine system to experimenteradministered nicotine (Imperato et al. 1986; Mifsud et al. 1989; Benwell and Balfour 1992; Benwell et al. 1993, 1995; Pontieri et al. 1996; Picciotto et al. 1998).”
ResultCo-activation of VTA DA and GABA neurons mediates nicotine reinforcement
Tolu, S., Eddine, R., Marti, F., David, V, Graupner, M., Pons, S., Baudonnat, M., Husson, M., Besson, M., Reperant, C., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.83 · Cited by 151
Feduccia, A. A., Chatterjee, S., & Bartlett, S. E. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00083 · Cited by 140
“For example, initial drug use will favor DA release in the NAc shell rather than the dorsolateral striatum (Pontieri et al., 1996; Di Chiara, 2002).”
BackgroundIncreased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats
Le Foll, B., Diaz, J., & Sokoloff, P. (2003) · Synapse · doi:10.1002/syn.10170 · Cited by 149
“E-mail: sokol@broca.inserm.fr or to Dr. Bernard Le Foll; E-mail: lefoll@broca.inserm.fr Received 29 April 2002; Accepted 17 September 2002 DOI 10.1002/syn.10170 © 2002 WILEY-LISS, INC. Pontieri et al., 1996).”
InfluentialMechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
“Despite widespread prevalence of tobacco smoking, it was not until the mid-1990s that there was a scientific consensus that nicotine is addictive in a similarmanner to other drugs of abuse such as cocaine (Stolerman and Jarvis, 1995; Pontieri et al., 1996; Pich et al., 1997).”
BackgroundLoland, C. J., Mereu, M., Okunola, O. M., Cao, J., Prisinzano, T. E., Mazier, S., Kopajtic, T., Shi, L., Katz, J. L., Tanda, G., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.022 · Cited by 144
Self-citationMateo, Y., Läck, C. M., Morgan, D., Roberts, D. C. S., & Jones, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300687 · Cited by 155
“Cocaine and amphetamine appear to preferentially increase glucose utilization in the shell compared with the core of the Nac, and morphine, nicotine, cocaine, and amphetamine preferentially increased extracellular DA in the shell over the core (Pontieri et al, 1995, 1996).”
BackgroundNicotine enhances responding with conditioned reinforcement
Olausson, P., Jentsch, J. D., & Taylor, J. R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1575-y · Cited by 154
Reinstatement and spontaneous recovery of nicotine seeking in rats
Shaham, Y., Adamson, L. K., Corrigall, W. A., & Grocki, S. (1997) · Psychopharmacology · doi:10.1007/s002130050256 · Cited by 157
“Nicotine, at doses comparable to those used in the present study, increases dopamine overflow in the nucleus accumbens (Di Chiara and Imperato 1988; Benwell and Balfour 1992; Nisell et al. 1994; Pontieri et al. 1996 ), a terminal region of the mesolimbic DA system implicated in the reinforcing (Koob and Bloom 1988; Wi…”
ResultSugar addiction: is it real? A narrative review
DiNicolantonio, J. J., O’Keefe, J. H., & Wilson, W. L. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-097971 · Cited by 129
Nicotine: the link between cigarette smoking and the progression of renal injury?
Jaimes, E. A., Tian, R.-X., & Raij, L. R. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00693.2006 · Cited by 158
“Nicotine is a major component of tobacco and responsible in large part for the psychoactive and addictive effects of cigarette smoking via its action in the central nervous system (34).”
Stress and smoking in adolescence: A test of directional hypotheses.
Wills, T. A., Sandy, J. M., & Yaeger, A. M. (2002) · Health Psychology · doi:10.1037//0278-6133.21.2.122 · Cited by 140
Adolescent brain maturation and smoking: What we know and where we’re headed
Lydon, D. M., Wilson, S. J., Child, A., & Geier, C. F. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.003 · Cited by 136
Berrendero, F., Mendizábal, V., Robledo, P., Galeote, L., Bilkei-Gorzo, A., Zimmer, A., & Maldonado, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3008-04.2005 · Cited by 138
“Nicotine has been reported to produce both rewarding and aversive responses by stimulating mesolimbic dopaminergic transmission (Pontieri et al., 1996; Dani and De Biasi, 2001; Laviolette and van der Kooy, 2003), which represents a common substrate for the motivational effects of many drugs of abuse (Koob and Le Moal,…”
BackgroundRada, P., Jensen, K., & Hoebel, B. (2001) · Psychopharmacology · doi:10.1007/s002130100781 · Cited by 141
“et al. 1989; Nissel et al. 1994; Summers and Giacobini 1995; Pontieri et al. 1996; Summers et al. 1996; Schilstrom et al. 1998; Takahashi et al. 1998; Balfour et al. 2000; Fu et al. 2000), whereas, injecting nicotinedependent animals with a specific nicotine antagonist, mecamylamine, produces the opposite effect on DA…”
BackgroundBerrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140
Hendrickson, L. M., Guildford, M. J., & Tapper, A. R. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00029 · Cited by 129
“…properties of ethanol and nicotine, as with most drugs of abuse, are associated with an increase in DA release in the NAc (Di Chiara and Imperato, 1988; Lewis and June, 1990; Benwell and Balfour, 1992; Samson et al., 1992; Diana et al., 1993; Weiss et al., 1993; Lanca, 1994; Pontieri et al., 1996).”
BackgroundPedersen, W., & Von Soest, T. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02395.x · Cited by 133
Scherma, M., Panlilio, L. V., Fadda, P., Fattore, L., Gamaleddin, I., Le Foll, B., Justinová, Z., Mikics, E., Haller, J., Medalie, J., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142224 · Cited by 138
“…its ability to activate the mesolimbic dopaminergic system by enhancing firing rate and burst firing of dopaminergic neurons in the ventral tegmental area (VTA) (Mereu et al., 1987) and increasing dopamine release in terminal areas, especially in the nucleus accumbens shell (Pontieri et al., 1996).”
BackgroundSelf-citationFu, Y., Matta, S. G., Gao, W., Brower, V. G., & Sharp, B. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39093-7 · Cited by 140
“, 1992) This holds, as well, for other addictive substances, such as cocaine, opiates, and alcohol (Nisell et al., 1995; Pontieri et al., 1996; Rose and Corrigall, 1997).”
Beuten, J., Payne, T. J., Ma, J. Z., & Li, M. D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300997 · Cited by 156
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior
Hu, S., Brody, C., Fisher, C., Gunzerath, L., Nelson, M. L., Sabol, S. Z., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Murphy, D. L., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000690 · Cited by 142
Maritz, G. S., & Harding, R. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8030875 · Cited by 130
“affinity nAChRs are found in the membranes of normal lung cells and in lung cancer cells of all histological types [49-51].”
BackgroundNicotine and angiogenesis: a new paradigm for tobacco‐related diseases
Cooke, J., & Bitterman, H. (2004) · Annals of Medicine · doi:10.1080/07853890310017576 · Cited by 135
The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155457 · Cited by 135
“, 1986), and subsequent dopamine release in the nucleus accumbens (NAc) is a process thought to underlie the rewarding and reinforcing properties of nicotine (Pontieri et al., 1996).”
BackgroundHuang, W., Payne, T. J., Ma, J. Z., Beuten, J., Dupont, R. T., Inohara, N., & Li, M. D. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.37 · Cited by 142
“Exposure to nicotine increases neurotransmitter dopamine release (Nisell et al, 1994; Pontieri et al, 1996).”
BackgroundChen, R.-J., Ho, Y., Guo, H., & Wang, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn086 · Cited by 142
“In the brain, nicotine exerts its action mainly through the nicotinic acetylcholine receptor (nAChR) (Pontieri et al., 1996).”
BackgroundAssociations between smoking cessation and anxiety and depression among U.S. adults
Regan, A. K., Dube, S. R., Strine, T. W., Kroenke, K., Caraballo, R. S., & Mokdad, A. H. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.01.005 · Cited by 146
IMPACT OF NICOTINE REPLACEMENT THERAPY ON SMOKING BEHAVIOR
Cummings, K. M., & Hyland, A. (2005) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144501 · Cited by 131
“Nicotine creates dependence by activating the mesolimbic dopaminergic reward system, and physiologic withdrawal symptoms occur when nicotine is no longer administered (59, 67, 71).”
BackgroundReduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132
“Nicotine causes greater dopamine release in the NAc than in other parts of the striatum (Pontieri et al., 1996), and this was the structure where we found the greatest reduction in D1 receptors in smokers.”
BackgroundRichards, J. M., Stipelman, B. A., Bornovalova, M. A., Daughters, S. B., Sinha, R., & Lejuez, C. W. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.06.009 · Cited by 132
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 126
“are suggested to be related to increased DA in striatal and limbic (NAc and amygdala) regions (44, 45); the latter reflects further compulsive substance intake, loss of control, and persistent intake despite the substance’s adverse effects and tolerance to its pleasurable responses (44, 46, 47).”
BackgroundFowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
“…dopamine release in the NAc (Andersson et al., 1981; Di Chiara and Imperato, 1988; Benwell and Balfour, 1992), particularly the shell region of the NAc (Pontieri et al., 1996), but also in other mesolimbic terminal regions, such as the bed nucleus of the stria terminalis (Carboni et al., 2000).”
BackgroundWenzel, J. M., Rauscher, N. A., Cheer, J. F., & Oleson, E. B. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500255p · Cited by 131
Smoking in Schizophrenia: Diagnostic Specificity, Symptom Correlates, and Illness Severity
Kotov, R., Guey, L. T., Bromet, E. J., & Schwartz, J. E. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn066 · Cited by 132
Sex Differences in Nicotine Action
Pöğün, Ş., & Yararbaş, G. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_10 · Cited by 130
Wills, T. A., Sandy, J. M., & Shinar, O. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.7.2.122 · Cited by 111
Wu, C., Lee, C., & Ho, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2434 · Cited by 131
“then migrate through the tissue to form new endothelialized channels (51, 52).”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Dewey, S. L., Hitzemann, R., Gifford, A. N., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37918-2 · Cited by 125
“Another limitation for the study is that measurements were made in the dorsal striatum and not in the nucleus accumbens, the structure in the striatum associated with drug reinforcement in laboratory animals (Pettit et al., 1984; Pontieri et al., 1996); however, DAT occupancy by MP should not differ appreciably betwee…”
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.